These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 12627713)
1. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713 [TBL] [Abstract][Full Text] [Related]
2. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Brown HM; Wilkinson EJ Hum Pathol; 2002 May; 33(5):545-8. PubMed ID: 12094381 [TBL] [Abstract][Full Text] [Related]
3. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922 [TBL] [Abstract][Full Text] [Related]
4. Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder. Sledge DG; Patrick DJ; Fitzgerald SD; Xie Y; Kiupel M Vet Pathol; 2015 Jan; 52(1):74-82. PubMed ID: 24608632 [TBL] [Abstract][Full Text] [Related]
5. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819 [TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder. Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650 [TBL] [Abstract][Full Text] [Related]
7. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas]. Moll R; Laufer J; Wu XR; Sun TT Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294 [TBL] [Abstract][Full Text] [Related]
8. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats. Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780 [TBL] [Abstract][Full Text] [Related]
10. Uroplakin expression in the urothelial tumors of cows. Ambrosio V; Borzacchiello G; Bruno F; Galati P; Roperto F Vet Pathol; 2001 Nov; 38(6):657-60. PubMed ID: 11732799 [TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas. Espinosa de los Monteros A; Fernández A; Millán MY; Rodríguez F; Herráez P; Martín de las Mulas J Vet Pathol; 1999 May; 36(3):179-90. PubMed ID: 10332826 [TBL] [Abstract][Full Text] [Related]
12. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018 [TBL] [Abstract][Full Text] [Related]
14. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Gaisa NT; Braunschweig T; Reimer N; Bornemann J; Eltze E; Siegert S; Toma M; Villa L; Hartmann A; Knuechel R Virchows Arch; 2011 Mar; 458(3):301-12. PubMed ID: 21136076 [TBL] [Abstract][Full Text] [Related]
15. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302 [TBL] [Abstract][Full Text] [Related]
17. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens. Xu X; Genega EM; Nasuti JF Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma. Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067 [TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977 [TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]